Prudent Man Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.49K Hold
100
﹤0.01% 143
2026
Q1
$2.49K Hold
100
﹤0.01% 143
2025
Q4
$2.49K Sell
100
-234
-70% -$5.9K ﹤0.01% 143
2025
Q3
$8.86K Hold
334
﹤0.01% 93
2025
Q2
$8.86K Hold
334
﹤0.01% 93
2025
Q1
$8.86K Hold
334
﹤0.01% 93
2024
Q4
$8.86K Buy
+334
New +$9.06K ﹤0.01% 93

Other funds holding PFE

Prudent Man Investment Management's PFE Position: Q2 2026 in Review

Prudent Man Investment Management held its Pfizer (PFE) position steady in Q2 2026 at 100 shares worth $2.49K. The position accounts for ﹤0.01% of the portfolio, ranked #143.

Prudent Man Investment Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.86K in Q3 2025. 1,459 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Prudent Man Investment Management held 100 shares of Pfizer worth $2.49K as of Q2 2026.
  • Prudent Man Investment Management left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up ﹤0.01% of Prudent Man Investment Management's portfolio in Q2 2026, its #143 holding.
  • Prudent Man Investment Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Prudent Man Investment Management's Pfizer position peaked at $8.86K in Q3 2025.
  • 1,459 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Prudent Man Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.